ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XNCR vs VERA // NET PROFIT MARGIN

Xencor Inc. (NASDAQ) VS. Vera Therapeutics Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: XNCR 4 — VERA 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XNCR VS. VERA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XNCR VERA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -21.30% -35.00% +13.70 XNCR /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.37% -10.99% +4.62 XNCR /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) 13.70% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 4.32 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 XNCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 66.2 52.7 +13.50 XNCR /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.22B $2.23B -$15.3M VERA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XNCR REV VERA REV XNCR GROSS % VERA GROSS % XNCR FCF VERA FCF
FY 2025 $125.6M $883.3M — — -$138.3M -$241.7M
FY 2024 $110.5M $468.1M — — -$208.3M -$135.7M
FY 2023 $174.6M $285.6M — — -$77.9M -$92.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XNCR // BETA —
VERA // BETA —